Work

Use of a Disease-Specific Comorbidity Index To Describe Elderly Patients with Acute Myelogenous Leukemia (AML) and High Risk Myelodysplasia (MDS) Enrolled in a Phase II Study of CLORETAZINE™ (VNP40101M).

Year: 2005

Type: article

Source: Blood

DOI: 10.1182/blood.v106.11.2787.2787

Authors: Francis Giles, David Rizzieri, Judith Karp, Norbert Vey, Khuda Khan, Ghulam Mufti, Diana Hudak, Verena Karsten, Susan O’Brien

Institutions: The University of Texas MD Anderson Cancer Center, Duke Medical Center, Johns Hopkins University, Institut Paoli-Calmettes, King's College London, Vion Pharmaceuticals (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2554022813

FWCI: 0.195

Cites:

Cited by: 1

Related to: 10